Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q2 2022 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2022-08-12

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value: $143M (100.0% shares, 0.0% debt)

Holdings (14)

— Pardes Biosciences Inc 20.2%

Value $28.86M Shares 9,400,515 Est. Cost $16.37 Unrealized —

— Theseus Pharmaceuticals, Inc. 12.9%

Value $18.44M Shares 3,335,346 Est. Cost $12.42 Unrealized —

ACRS Aclaris Therapeutics, Inc. 12.3%

Value $17.57M Shares 1,258,243 Est. Cost $19.56 Unrealized -28.3%

— Somalogic, Inc. 11.1%

Value $15.89M Shares 3,516,472 Est. Cost $12.39 Unrealized —

HIMS Hims & Hers Health, Inc. 10.5%

Value $15.04M Shares 3,319,786 Est. Cost $9.03 Unrealized -52.8%

CMPX Compass Therapeutics, Inc. 8.1%

Value $11.66M Shares 4,400,000 Est. Cost $3.29 Unrealized -34.0%

— Kinnate Biopharma Inc. 7.7%

Value $11.03M Shares 875,001 Est. Cost $39.78 Unrealized —

— Adicet Bio, Inc. 6.9%

Value $9.928M Shares 680,000 Est. Cost $17.49 Unrealized —

IVVD Adagio Therapeutics, Inc. 3.3%

Value $4.696M Shares 1,431,826 Est. Cost $34.15 Unrealized -90.8%

— Gemini Therapeutics, Inc. 2.9%

Value $4.115M Shares 2,435,125 Est. Cost $13.55 Unrealized —

QSI Quantum-Si Incorporated 1.5%

Value $2.145M Shares 924,379 Est. Cost $10.48 Unrealized -63.4%

ENTA Enanta Pharmaceuticals, Inc. 1.4%

Value $1.997M Shares 42,250 Est. Cost $65.07 Unrealized -16.6%

— 23andMe Holding Co. 0.7%

Value $1.009M Shares 406,913 Est. Cost $11.69 Unrealized —

PHVS Pharvaris N.V. 0.5%

Value $755K Shares 34,142 Est. Cost $31.46 Unrealized -40.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Pardes Biosciences Inc	9,400,515	$28.86M	20.2%	$16.37	—	COM	69945Q105
—	Theseus Pharmaceuticals, Inc.	3,335,346	$18.44M	12.9%	$12.42	—	COM	88369M101
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$17.57M	12.3%	$19.56	-28.3%	COM	00461U105
—	Somalogic, Inc.	3,516,472	$15.89M	11.1%	$12.39	—	COM CL A	83444K105
HIMS	Hims & Hers Health, Inc.	3,319,786	$15.04M	10.5%	$9.03	-52.8%	COM CL A	433000106
CMPX	Compass Therapeutics, Inc.	4,400,000	$11.66M	8.1%	$3.29	-34.0%	COM	20454B104
—	Kinnate Biopharma Inc.	875,001	$11.03M	7.7%	$39.78	—	COM	49705R105
—	Adicet Bio, Inc.	680,000	$9.928M	6.9%	$17.49	—	COM	007002108
IVVD	Adagio Therapeutics, Inc.	1,431,826	$4.696M	3.3%	$34.15	-90.8%	COM	00534A102
—	Gemini Therapeutics, Inc.	2,435,125	$4.115M	2.9%	$13.55	—	COM	36870G105
QSI	Quantum-Si Incorporated	924,379	$2.145M	1.5%	$10.48	-63.4%	COM CL A	74765K105
ENTA	Enanta Pharmaceuticals, Inc.	42,250	$1.997M	1.4%	$65.07	-16.6%	COM	29251M106
—	23andMe Holding Co.	406,913	$1.009M	0.7%	$11.69	—	COM CL A	90138Q108
PHVS	Pharvaris N.V.	34,142	$755K	0.5%	$31.46	-40.8%	COM	N69605108